Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$208M |
| 2 |
Lowe's Companies
LOW
|
+$198M |
| 3 |
American Tower
AMT
|
+$161M |
| 4 |
Lennar Class A
LEN
|
+$150M |
| 5 |
British American Tobacco
BTI
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$208M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$177M |
| 3 |
Crown Castle
CCI
|
+$168M |
| 4 |
Walmart Inc
WMT
|
+$167M |
| 5 |
Entergy
ETR
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.75% |
| 2 | Technology | 13.18% |
| 3 | Healthcare | 11.51% |
| 4 | Industrials | 10.45% |
| 5 | Consumer Discretionary | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Inogen
INGN
$148M
| $4.11M | 0.01% |
43,212
-19,015
| -31% | -$1.83M |
|
|
DENN
1777
DELISTED
Denny's
DENN
| $4.1M | 0.01% |
329,020
+182,801
| +125% | +$2.17M |
|
1778
Karyopharm Therapeutics
KPTI
$44.5M
| $4.07M | 0.01% |
24,728
+10,118
| +69% | +$1.45M |
|
1779
1-800-Flowers.com
FLWS
$240M
| $4.06M | 0.01% |
412,131
+318,093
| +338% | +$2.98M |
|
1780
Abeona Therapeutics
ABEO
$344M
| $4.05M | 0.01% |
+9,501
| New | +$2.55M |
|
1781
Myers Industries
MYE
$1.25B
| $4.04M | 0.01% |
192,775
+94,029
| +95% | +$1.73M |
|
|
CAI
1782
DELISTED
CAI International, Inc.
CAI
| $4.03M | 0.01% |
133,056
+108,782
| +448% | +$3M |
|
1783
Sasol
SSL
$7.28B
| $4.02M | 0.01% |
145,936
+85,112
| +140% | +$2.5M |
|
1784
Banco Bradesco
BBD
$35.5B
| $4.02M | 0.01% |
637,472
-2,491,100
| -80% | -$14.5M |
|
1785
NBT Bancorp
NBTB
$2.68B
| $4.02M | 0.01% |
109,383
+92,328
| +541% | +$3.22M |
|
1786
CALL
Franklin Templeton
BEN
$17.8B
| $4.01M | 0.01% |
+90,000
| New | +$3.94M |
|
|
PXD
1787
DELISTED
Pioneer Natural Resource Co.
PXD
| $3.99M | 0.01% |
27,057
-17,875
| -40% | -$2.57M |
|
|
CWEN.A
1788
DELISTED
Clearway Energy Class A
CWEN.A
| $3.99M | 0.01% |
210,151
-37,963
| -15% | -$687K |
|
1789
OneMain Financial
OMF
$7.26B
| $3.99M | 0.01% |
141,431
-424,587
| -75% | -$11.4M |
|
|
FRAN
1790
DELISTED
Francesca's Holdings Corporation
FRAN
| $3.98M | 0.01% |
45,024
+27,666
| +159% | +$2.8M |
|
1791
DXP Enterprises
DXPE
$2.96B
| $3.97M | 0.01% |
126,166
+30,896
| +32% | +$920K |
|
|
NVTR
1792
DELISTED
Nuvectra Corporation Common Stock
NVTR
| $3.97M | 0.01% |
299,079
+194,664
| +186% | +$2.3M |
|
1793
CorVel
CRVL
$3.55B
| $3.96M | 0.01% |
218,637
+155,637
| +247% | +$2.6M |
|
1794
LSB Industries
LXU
$749M
| $3.96M | 0.01% |
648,323
+601,546
| +1,286% | +$3.6M |
|
1795
Travel + Leisure Co
TNL
$4.51B
| $3.95M | 0.01% |
+83,089
| New | +$3.79M |
|
1796
TD Synnex
SNX
$20.4B
| $3.94M | 0.01% |
62,344
-29,338
| -32% | -$1.73M |
|
|
VRTU
1797
DELISTED
Virtusa Corporation
VRTU
| $3.94M | 0.01% |
104,386
-85,504
| -45% | -$2.94M |
|
|
FOMX
1798
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $3.94M | 0.01% |
709,775
+586,690
| +477% | +$3.03M |
|
1799
Aldeyra Therapeutics
ALDX
$94.1M
| $3.92M | 0.01% |
545,085
+444,585
| +442% | +$2.32M |
|
1800
Rapid7
RPD
$795M
| $3.92M | 0.01% |
222,737
-36,098
| -14% | -$599K |
|
Similar funds
Israel Englander's Q3 2017 Portfolio in Review
As of Q3 2017, Israel Englander held 4,198 positions worth $65.6B, up 17% from $56.1B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.
Israel Englander deployed $6.37B of net new capital in Q3 2017, opening 794 new positions and adding to 1,441 existing holdings. Its largest new stake was Northern Trust: 1,591,041 shares worth $146M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $208M trimmed.
- Israel Englander's largest Q3 2017 buy was Northern Trust: 1,591,041 shares worth $146M.
- Israel Englander added most to Salesforce in Q3 2017, an estimated $208M increase.
- Israel Englander's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $208M.
- Israel Englander fully exited CONCHO RESOURCES INC. in Q3 2017, selling an estimated $177M.
- Israel Englander's ten largest holdings make up 7.8% of its $65.6B portfolio in Q3 2017.
- Israel Englander opened 794 new positions and closed 737 in Q3 2017.
- Israel Englander's portfolio value rose 17% quarter-over-quarter to $65.6B.
Based on Millennium Management's 13F filing for Q3 2017, filed 14 Nov 2017.